PL140992B1 - Process for preparing novel derivatives of piperidinedione - Google Patents

Process for preparing novel derivatives of piperidinedione

Info

Publication number
PL140992B1
PL140992B1 PL1983249749A PL24974983A PL140992B1 PL 140992 B1 PL140992 B1 PL 140992B1 PL 1983249749 A PL1983249749 A PL 1983249749A PL 24974983 A PL24974983 A PL 24974983A PL 140992 B1 PL140992 B1 PL 140992B1
Authority
PL
Poland
Prior art keywords
formula
product
compound
group
piperidinedione
Prior art date
Application number
PL1983249749A
Other languages
English (en)
Polish (pl)
Other versions
PL249749A1 (en
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of PL249749A1 publication Critical patent/PL249749A1/xx
Publication of PL140992B1 publication Critical patent/PL140992B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL1983249749A 1982-11-08 1983-11-08 Process for preparing novel derivatives of piperidinedione PL140992B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8218706A FR2535721A1 (fr) 1982-11-08 1982-11-08 Derives de la piperidinedione protecteurs du myocarde presentant une acticite antiarythmique, leur procede de preparation et les medicaments qui contiennent lesdits derives

Publications (2)

Publication Number Publication Date
PL249749A1 PL249749A1 (en) 1985-03-12
PL140992B1 true PL140992B1 (en) 1987-06-30

Family

ID=9279000

Family Applications (3)

Application Number Title Priority Date Filing Date
PL1983249750A PL140021B1 (en) 1982-11-08 1983-11-08 Process for preparing novel derivatives of piperidinedione
PL1983249749A PL140992B1 (en) 1982-11-08 1983-11-08 Process for preparing novel derivatives of piperidinedione
PL1983244462A PL139946B1 (en) 1982-11-08 1983-11-08 Process for preparing novel derivatives of piperidinediones

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL1983249750A PL140021B1 (en) 1982-11-08 1983-11-08 Process for preparing novel derivatives of piperidinedione

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1983244462A PL139946B1 (en) 1982-11-08 1983-11-08 Process for preparing novel derivatives of piperidinediones

Country Status (29)

Country Link
US (1) US4721710A (OSRAM)
EP (1) EP0110755B1 (OSRAM)
JP (1) JPS59161377A (OSRAM)
KR (1) KR900006721B1 (OSRAM)
AT (1) ATE22561T1 (OSRAM)
AU (1) AU565519B2 (OSRAM)
CA (1) CA1221967A (OSRAM)
CS (1) CS244681B2 (OSRAM)
DD (3) DD219770A5 (OSRAM)
DE (1) DE3366623D1 (OSRAM)
DK (1) DK511383A (OSRAM)
ES (1) ES8406070A1 (OSRAM)
FI (1) FI79536C (OSRAM)
FR (1) FR2535721A1 (OSRAM)
GR (1) GR78747B (OSRAM)
HU (1) HU191494B (OSRAM)
IE (1) IE56209B1 (OSRAM)
IL (1) IL70099A (OSRAM)
MA (1) MA19948A1 (OSRAM)
NO (1) NO159852C (OSRAM)
NZ (1) NZ206177A (OSRAM)
OA (1) OA07582A (OSRAM)
PH (1) PH20421A (OSRAM)
PL (3) PL140021B1 (OSRAM)
PT (1) PT77607B (OSRAM)
SG (1) SG1989G (OSRAM)
SU (3) SU1333237A3 (OSRAM)
YU (3) YU221183A (OSRAM)
ZA (1) ZA838065B (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668689A (en) * 1984-07-19 1987-05-26 National Research Development Corporation Glutarimide derivatives for treating oestrogen-dependent tumors
US5238947A (en) * 1990-04-12 1993-08-24 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
US5463063A (en) * 1993-07-02 1995-10-31 Celgene Corporation Ring closure of N-phthaloylglutamines
DE19703763C1 (de) * 1997-02-01 1998-10-01 Gruenenthal Gmbh Thalidomidanaloge Verbindungen aus der Klasse der Piperidin-2,6-Dione
BR112013029508B1 (pt) 2011-05-17 2022-05-03 Principia Biopharma, Inc. Composto, composição farmacêutica, e, uso do referido composto
US9376438B2 (en) 2011-05-17 2016-06-28 Principia Biopharma, Inc. Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
CN103534258B (zh) 2011-05-17 2016-09-14 普林斯匹亚生物制药公司 酪氨酸激酶抑制剂
LT3181567T (lt) 2012-09-10 2019-07-25 Principia Biopharma Inc. Pirazolpirimidino junginiai kaip kinazės slopikliai
US8957080B2 (en) 2013-04-09 2015-02-17 Principia Biopharma Inc. Tyrosine kinase inhibitors
KR20220027271A (ko) 2014-02-21 2022-03-07 프린시피아 바이오파마, 인코퍼레이티드 Btk 억제제의 염 및 고체 형태
ES2843323T3 (es) 2014-12-18 2021-07-16 Principia Biopharma Inc Tratamiento de pénfigo
US20180305350A1 (en) 2015-06-24 2018-10-25 Principia Biopharma Inc. Tyrosine kinase inhibitors
CN109600989B (zh) 2016-06-29 2022-11-04 普林斯匹亚生物制药公司 2-[3-[4-氨基-3-(2-氟-4-苯氧基-苯基)吡唑并[3,4-d]嘧啶-1-基]哌啶-1-羰基]-4-甲基-4-[4-(氧杂环丁烷-3-基)哌嗪-1-基]戊-2-烯腈的改性的释放制剂
KR20220080179A (ko) 2019-10-14 2022-06-14 프린시피아 바이오파마, 인코퍼레이티드 (R)-2-[3-[4-아미노-3-(2-플루오로-4-페녹시-페닐)피라졸로[3,4-d]피리미딘-1-일]피페리딘-1-카르보닐]-4-메틸-4-[4-(옥세탄-3-일)피페라진-1-일]펜트-2-엔니트릴을 투여하여 면역 혈소판 감소증을 치료하는 방법
KR20220130184A (ko) 2020-01-22 2022-09-26 프린시피아 바이오파마, 인코퍼레이티드 2-[3-[4-아미노-3-(2-플루오로-4-페녹시-페닐)-1H-피라졸로[3,4-d]피리미딘-1-일]피페리딘-1-카르보닐]-4-메틸-4-[4-(옥세탄-3-일)피페라진-1-일]펜트-2-엔니트릴의 결정질 형태

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2664424A (en) * 1953-12-29 Dioxo-piperidines
GB1455687A (en) * 1972-12-28 1976-11-17 Aspro Nicholas Ltd Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines
FR2467200A1 (fr) * 1979-10-11 1981-04-17 Clin Midy Derives du pyrrole actifs sur les troubles du rythme cardiovasculaire

Also Published As

Publication number Publication date
YU221183A (en) 1986-06-30
DK511383D0 (da) 1983-11-08
NO834057L (no) 1984-05-09
NO159852C (no) 1989-02-15
FI834087A0 (fi) 1983-11-08
ATE22561T1 (de) 1986-10-15
PT77607B (fr) 1986-03-18
PL244462A1 (en) 1985-02-13
DE3366623D1 (en) 1986-11-06
ES527091A0 (es) 1984-07-01
PL249749A1 (en) 1985-03-12
JPS59161377A (ja) 1984-09-12
KR900006721B1 (ko) 1990-09-20
PT77607A (fr) 1983-12-01
FI834087L (fi) 1984-05-09
OA07582A (fr) 1985-03-31
DD219770A5 (de) 1985-03-13
US4721710A (en) 1988-01-26
DD229402A5 (de) 1985-11-06
SG1989G (en) 1989-06-02
IE56209B1 (en) 1991-05-22
GR78747B (OSRAM) 1984-10-02
DD229407A5 (de) 1985-11-06
SU1316558A3 (ru) 1987-06-07
EP0110755A1 (fr) 1984-06-13
SU1333238A3 (ru) 1987-08-23
YU184185A (en) 1986-06-30
NZ206177A (en) 1985-11-08
YU184285A (en) 1986-06-30
AU2089883A (en) 1984-05-17
MA19948A1 (fr) 1984-07-01
PL140021B1 (en) 1987-03-31
EP0110755B1 (fr) 1986-10-01
HU191494B (en) 1987-02-27
FR2535721A1 (fr) 1984-05-11
SU1333237A3 (ru) 1987-08-23
IL70099A0 (en) 1984-01-31
PH20421A (en) 1987-01-05
IL70099A (en) 1987-10-20
NO159852B (no) 1988-11-07
CS244681B2 (en) 1986-08-14
CA1221967A (en) 1987-05-19
PL139946B1 (en) 1987-03-31
KR840006641A (ko) 1984-12-01
ZA838065B (en) 1984-06-27
FI79536C (fi) 1990-01-10
DK511383A (da) 1984-05-09
ES8406070A1 (es) 1984-07-01
IE832581L (en) 1984-05-08
PL249750A1 (en) 1985-03-12
FR2535721B1 (OSRAM) 1985-05-17
AU565519B2 (en) 1987-09-17
FI79536B (fi) 1989-09-29

Similar Documents

Publication Publication Date Title
DE60302336T2 (de) Neue pyridin- und quinolin-derivate
DE2923815C2 (OSRAM)
CA1038871A (en) Process for the preparation of new pyridine derivatives
EP1339717B1 (de) Neue carbamat-substituierte pyrazolopyridinderivate
PL140992B1 (en) Process for preparing novel derivatives of piperidinedione
DD283395A5 (de) Verfahren zur herstellung von tetrahydropyridinen
CS240998B2 (en) Production method of 1,4-dihydropiridines
WO2003086407A1 (de) Verwendung von stimulatoren der löslichen guanylatcyclase zur behandlung von glaukom
SU1230467A3 (ru) Способ получени производных 1-циклогексил-4-арил-4-пиперидинкарбоновых кислот,или их кислотно-аддитивных солей,или их стереохимических изомерных форм (его варианты)
US4501745A (en) Anxiolytic imidazo[1,2-a]pyridine derivatives
US4492695A (en) Therapeutically useful imidazo[1,2-a]pyridine derivatives
RU1830063C (ru) Способ получени замещенных 1-(1Н-имидазол-4-ил)-алкилбензамидов или их солей присоединени с кислотами нетоксичными и фармацевтически приемлемыми
JPH0625091B2 (ja) ジヒドロジベンゾシクロヘプチリデン―エチルアミン誘導体その製法ならびに医薬組成物
DE10244810A1 (de) Neue Morpholin-überbrückte Indazolderivate
US4940789A (en) 10,11-dihydro-5-alkyl-12-substituted-10,5-(iminomethano)-5H-dibenzo[a,d]cycloheptenes as neuroprotectant agents
FR2593818A1 (fr) Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique
JPH085864B2 (ja) 新規なアコニチン系化合物およびそれらを有効成分とする鎮痛・抗炎症剤
US4757079A (en) Anti-hypertensive piperidine compounds
US5508401A (en) Substituted dibenzo[a,d]cycloheptene NMDA antagonists
US5912348A (en) Method of making arylamino triazolopyridines
DE69018741T2 (de) Konjugierte gamma-Hydroxybutenolid-Derivate und sie als aktiver Wirkstoff enthaltende Mittel gegen Magengeschwüre.
US4883796A (en) Oxime ethers of 2,6-dioxabicyclo(3.3.0)octanones, and compositions and methods for treatment of a cardiac disease or circulatory with them
JPS5910359B2 (ja) シンキナチツソガンユウタカンカゴウブツ ノ チヨウセイホウホウ
DE3741005A1 (de) Aminopropanol-derivate von 1,4:3,6-dianhydro-hexit-nitraten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO1999062865A1 (en) Haloethyl-2-[ (2,6-dichlorophenyl) amino] phenylacetoxyacetate derivatives and their use as an intermediate to synthesize aceclofenac